Gentilella, R., Pechtner, V., Corcos, A
These molecules are important mediators of inflammation, immune response, and blood clotting
Nature 569 , 565569 (2019)
Regulatory & Legal Status AOD-9604 has no FDA-approved therapeutic use and has never been cleared for human consumption by any government health authority worldwide it exists in a pre-clinical/discontinued-development status, which is the basis for its banned classification
Because of its high prevalence in conjunction with obesity, diabetes, and insulin resistance, NAFLD has been increasingly appreciated as a hepatic manifestation of metabolic syndrome and is the leading cause of death from liver disease in the United States 1,2,3
YXH2024YS039), and Research Fund of Qianfoshan Hospital (grant no